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Using life saving commodities to save lives globally
The UN Commission on Life Saving Commodities 
(UNCoLSC) was established in 2012 with an explicit aim 
to secure a steady supply of key commodities across 
reproductive, maternal, newborn, and child health 
(RMNCH).1 Although late in the process of accelerating 
progress to reach the Millennium Development Goals, 
the UNCoLSC targeted securement of the supply and 
uptake of 13 life saving commodities in low-income 
and middle-income countries through various actions 
including market shaping, regulatory eﬃ  ciency, 
innovative ﬁ nancing, demand creation, and targeting 
women and children at greatest risk. The evaluation 
by Pronyk and colleagues2 presents a situational and 
bottleneck analysis of progress in 12 of the 18 sub-
Saharan African countries that received RMNCH trust 
funds and were evaluated from 2013 to 2015.  
The mixed methods approach that was used relied on 
a range of participants and informants, and since the 
evaluation was not independent, this could well have 
overestimated progress and readiness in some countries. 
These issues not withstanding, the report details a 
mixed bag of progress and lack thereof. The bottlenecks 
identiﬁ ed are well recognised3,4 and range from an 
almost universally inadequate regulatory and quality 
assurance environment and supply chain, to insuﬃ  cient 
staﬀ  training and persistent stock-outs in almost 
half of the facilities evaluated. Of the US$200 million 
disbursed so far, almost 70% of the funds were spent on 
systems strengthening ($89 million on staﬀ  training, 
mentorship, and support and $53 million for district-
level monitoring and evaluation). Given the early stage 
of implementation and procurements, the $21 million 
spent on community mobilisation and advocacy, a 
mean of $2 million per country over the last 2–3 years, 
seems excessive. 
This question of value for money is important, 
as only a small proportion of the funds released 
since 2012 have actually gone towards procuring 
commodities. Although establishing a framework 
for global consensus, establishing supply chains, 
and understanding bottlenecks are important, the 
fundamental accountability lies in ensuring that life 
saving commodities reach the poorest of the poor. Many 
of the issues identiﬁ ed with procurements, market 
shaping, systems gaps, and the balance of push and 
pull factors are common to the experience of the Global 
Fund around commodities for malaria, tuberculosis, and 
HIV,5,6 and the training gaps are not dissimilar. I wonder 
whether a more eﬃ  cient and rapid review process was 
possible given that many of the countries targeted are 
also Global Fund recipients.
Another key question is the nature of commodities 
targeted by the UNCoLSC. Although a series of 
technical committees provided input, the selection 
of speciﬁ c commodities was not standardised on 
parameters of global evidence, consensus, and WHO 
recommendations. For example, although the case 
for deploying antenatal steroids for saving newborn 
lives was built through a technical review process,7 
there were no examples of successful use of antenatal 
steroids among health systems in low-income and 
middle-income countries. The substantial adverse 
eﬀ ects experienced in a recent multicountry study of 
antenatal steroids,8 possibly as a result of inappropriate 
targeting by health workers, led to a reconsideration 
of their use at scale before addressing key questions 
around implementation in health systems. This work 
and implementation research is led by WHO, but does 
question aggressive promotion of certain commodities 
in the absence of clear WHO guidelines and relevant 
safety data from low-income and middle-income 
countries. Similarly, ﬁ ndings from the 12 countries 
of poor community demand and facility bottlenecks 
for the use of emergency contraception and female 
condoms2 also raises issues of sequencing and the 
necessity of developing community demand and social 
marketing around such commodities. As suggested 
by Dawson and colleagues,9 the role of the private 
sector in providing emergency contraception is 
increasingly recognised and underscores the importance 
of appropriate public–private partnerships and 
performance enhancement strategies. There is therefore 
a need to revisit the issue of commodity selection, and 
to focus on key diagnostics and other technologies that 
are clearly important for saving lives but may have been 
ignored so far. Simple diagnostics can help save lives 
across the continuum of care, such as pulse oximetry,10 
and simple technologies are essential for triaging 
babies at risk, such as low-cost weighing scales. One 
of the most important commodities in short supply in 
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low-income and middle-income countries is oxygen, 
which can make the diﬀ erence between saving the life 
of a critically ill mother or young infant. A formal gap 
analysis of key commodities and supply chain would 
greatly help in building a list of key commodities and 
delivery strategies. 
What lies ahead? Clearly the extremely ambitious goals 
and targets set by the UNCoLSC have not been reached,1 
and challenges must be overcome. While the current 
evaluation highlights several challenges and strategies 
for action, a clear process in moving forward would 
be to link this bottleneck analysis to the new global 
strategy for Every Woman Every Child, and therefore 
remain relevant to the Sustainable Development Goals. 
Can this work be linked to the ﬁ nancing opportunities 
and country-level microplanning being undertaken by 
the global ﬁ nancing facility of the World Bank? How 
can the work on commodities connect to the principles 
of universal health care, equity, and accountability, 
fundamental to the Sustainable Development Goals? It is 
time to move beyond the diagnostic to focus a lot more 
on implementation and achieving eﬀ ective coverage. 
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